IVUS-Guided Sirolimus-Coated Balloon Versus Sirolimus-Eluting Stent for De Novo Large Vessel Lesions in ACS

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.

Also called NCT07796412

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07796412
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07796412. Randomized; single masking; primary purpose treatment. Start 2026-12-01 (anticipated); primary completion 2028-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
IVUS-Guided Sirolimus-Coated Balloon Versus Sirolimus-Eluting Stent for De Novo Large Vessel Lesions in ACS
Acronym
IVUS-SCB
Condition
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI (percutaneous coronary intervention))
Intervention (Device)
IVUS-Guided Sirolimus-Coated Balloon
Intervention (Device)
IVUS-Guided Sirolimus-Eluting Stent
Lead sponsor
China National Center for Cardiovascular Diseases (class: other government)
Collaborator
B. Braun Medical International Trading Company Ltd. (class: industry)

Record details

Record id
cardio:ct-nct07796412
Content hash
c66741ad4cd7fd0a018d4ac7c08d5320f9d2ec51fa582553d6ab8e6c832a9059